ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Caliper Life Sciences, a supplier of screening and microfluidics systems for drug discovery research, is continuing its acquisition run. Caliper plans to acquire Xenogen, a manufacturer of advanced imaging systems for drug discovery, in a stock deal valued at approximately $80 million. Caliper acquired liquid-handling systems firm Zymark in 2003 for $71 million and screening and assay development firm NovaScreen BioSciences last year for $22 million.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X